Author - Ziad

Companies To Watch: CytoAgents

CytoAgents primarily focuses on developing a single lead drug, coded CTO1681, in multiple indications involving cytokine release syndrome (CRS). Simply stated, CRS is “an overreaction of the immune system, commonly known as cytokine storm.” It has many causes and affects many areas and systems of the body. CTO1681 targets the NF-kB (nuclear factor kappa B) signaling pathway to modulate cytokine production, thus reducing inflammation. CytoAgents has early programs in four areas: oncology (with CAR T-cell therapy), dermatology (atopic dermatitis), neurology...
Read more...

It’s now time to step on the gas pedal’: Group nears commercial production of single-cell protein for use in aquafeed

Massachusetts-based biotechnology company KnipBio said it is on the cusp of moving into commercial production after recently winning approval for its single-cell protein for use in salmon aquafeed in Canada. In the past year, the company has produced around 100 metric tons of its feed protein using third-party production facilities, having earlier gained regulatory approval in the United States for use in both finfish and shrimp feed. Within 15 months, or probably a little bit more than a year, is...
Read more...

Wasabi CEO David Friend: $250M Funding To Double Channel Reach, Fuel Global Expansion

Boston-based cloud storage company Wasabi Technologies this week said it has raised an additional $250 million in funding, half of which came from private equity and other institutional investors and half from debt, and said the company now has a valuation of over $1.1 billion. The new funding represents a big bet on Wasabi, which is using its large channel and alliance partner base to compete against cloud giants like Amazon Web Services by promising to provide cloud storage for...
Read more...

Entrepreneurs who succeeded against all odds

RAHUL SINGH, Co-Founder, EcoSoul Home Inc A global business leader and an entrepreneur at heart with a passion for environment sustainability, social transformation, and empowerment. Post his MBA from XLRI Jamshedpur, he built a successful career 15 years long career in Consulting, Banking and Ecommerce in New York, USA. Driven by his passion for environment and sustainability, he started his entrepreneurial journey from 2020 as the co-founder of EcoSoul Home Inc. Read more >>
Read more...

Landsdowne Labs and CBMM Form International Partnership Aimed at Enhancing Button Battery Safety for Children

With reports of a recent sharp rise in child ingestion of button batteries, Landsdowne Labs, LLC, a Fairfield, CT. spinout from the world-renowned Langer Lab at MIT, and CBMM, the global leader in Niobium products, are pleased to announce a partnership to further develop battery technology aimed at preventing severe injury or fatality if button batteries are swallowed. The patent-pending technology, under development by Landsdowne Labs, involves an innovative coating aimed at halting chemical reactions when batteries come into contact...
Read more...

Wasabi Technologies Reaches Unicorn Status

Boston, MA September 27th, 2022, Boston Harbor Angels (BHA) is pleased to announce that Wasabi Technologies, one of its portfolio companies, has reached Unicorn status with the close of $250M round of investment. “We are very happy for Wasabi Technologies, investors and Wasabi employees,” says Ziad Moukheiber, President and CEO of Boston Harbor Angels.  “David Friend, Founder and CEO of Wasabi Technologies is an exceptional entrepreneur. BHA is thrilled to have been part of this journey from the beginning and we...
Read more...

After dry spell, Boston has a new unicorn

Boston finally has a new unicorn after a nearly three-month dry spell for companies crossing the $1 billion valuation mark. Wasabi Technologies Inc. has become Boston's latest unicorn after raising $125 million in a Series D round led by L2 Point Management. The Boston-based company also announced the expansion of its debt facility with MGG Investment Group by $125 million. Wasabi said the $250 million in new funding puts its valuation over $1.1 billion. Read more >>
Read more...